Intrauterine baclofen exposure: a multidisciplinary approach

Lisa R Moran1, Pamela G Almeida, Susan Worden

  • 1Department of Pharmacy-GB005, Massachusetts General Hospital, 55 Fruit St, Boston, Massachusetts 02114, USA. lrmoran@partners.org

Pediatrics
|August 3, 2004
PubMed

Maternal use of the antispasmodic baclofen during pregnancy is an uncommon clinical scenario and leads to uncertainty regarding neonatal risks. We present a team-based, peripartum management plan designed for safe monitoring and minimizing the risk of neonatal withdrawal after unusual drug exposure. Incorporating the expertise of neonatology, nursing, pharmacy, neurology, and the lactation service, as well as parental input, this consensus approach was implemented in a case of maternal oral baclofen use with a successful outcome for the infant and family.